top of page

Linda Scoriels

Ph.D, HDR

Associate professor

Paris Cité University

Linda is a researcher at LaPsyDÉ and an associate professor in cognitive neuroscience at the Institute of Psychology, Université Paris Cité. She completed a Magistère in Genetics, followed by a Master's degree in Cognitive Neuroscience in Paris between 2002 and 2005. She then completed a PhD in Neuroscience at the University of Cambridge, UK, under the supervision of Peter Jones in 2010, followed by a first postdoctorate. Then, after obtaining a ‘Young Talent’ funding from the Brazilian government, Linda moved to the Federal University of Rio de Janeiro (UFRJ), where she completed her 2nd postdoctorate, followed by a position as substitute assistant professor in the UFRJ Faculty of Medicine. On her return to Paris in 2021, she joined the Krebs team at the Psychiatry and Neurosciences Institute of Paris, where she was appointed scientific director of two multicentre clinical trials in France. She co-directed the theses of Larissa Genaro (2018), Erica Woodruff (2018), Anna-Luiza Guimarães (2022), Valeria Lucarini (ongoing), Delphine Yeh (ongoing) on the role of cognitive and emotional functions in psychosis and ageing.

Her research focuses on the biological and environmental characterisation of cognitive and emotional processes in development, psychiatric disorders and ageing. She also seeks to develop pharmacological and digital cognitive enhancement strategies for these different populations, in order to improve cognitive and emotional processes, as well as functioning and quality of life of these individuals.

PUBLICATIONS

Frajerman, A., Urban, M., Rivollier, F., Plaze, M., Chaumette, B., Krebs, M.-O., & Scoriels, L. (2023). Abnormalities in one-carbon metabolism in young patients with psychosis. Frontiers in Psychiatry, 14, 1128890. https://doi.org/10.3389/fpsyt.2023.1128890

More

Mororó, L. G., Guimarães, A. L., Costa, A. C., Genaro, L., Cavalcanti, M. T., Scoriels, L., & Panizzutti, R. (2023). Association between motivation and engagement with changes in cognition and symptoms after digital cognitive training in schizophrenia. Schizophrenia Research, 251, 1–9. https://doi.org/10.1016/j.schres.2022.12.002

Couturier, A., Chaumette, B., Kebir, O., Iftimovici, A., Krebs, E., He, Q., Jiao, C., Krebs, M.-O., Scoriels, L., & Frajerman, A. (2022). The impact of BDNF on the cognitive functions of ultra-high risk patients: An exploratory study. Schizophrenia Research, S0920-9964(22)00432-7. https://doi.org/10.1016/j.schres.2022.11.016

Scoriels, L., Genaro, L. T., Keffer, S., Guimarães, A. L., Barros-Dumas, B., Mororó, L. G., Biagioni, T., Lucena, C., da Hora, T. R., Sahakian, B. J., Fisher, M., Vinogradov, S., & Panizzutti, R. (2022). Changes in emotion processing and social cognition with auditory versus visual neuroscience-informed cognitive training in individuals with schizophrenia. Schizophrenia Research, 241, 267–274. https://doi.org/10.1016/j.schres.2022.02.013

Guimarães, A. L., Richer Araujo Coelho, D., Scoriels, L., Mambrini, J., Ribeiro do Valle Antonelli, L., Henriques, P., Teixeira-Carvalho, A., Assis Martins Filho, O., Mineo, J., Bahia-Oliveira, L., & Panizzutti, R. (2022). Effects of Toxoplasma gondii infection on cognition, symptoms, and response to digital cognitive training in schizophrenia. Schizophrenia (Heidelberg, Germany), 8(1), 104. https://doi.org/10.1038/s41537-022-00292-2

More

Frajerman, A., Scoriels, L., Kebir, O., & Chaumette, B. (2021). Shared Biological Pathways between Antipsychotics and Omega-3 Fatty Acids: A Key Feature for Schizophrenia Preventive Treatment? International Journal of Molecular Sciences, 22(13), Article 13. https://doi.org/10.3390/ijms22136881

More

Genaro, L. T., Santos, P. V., Mororó, L. G. C., Panizzutti, R., & Scoriels, L. (2021). The psychometric properties of the Behavioral Inhibition and Activation Systems motivational scale and a Brazilian Portuguese validation. Learning and Motivation, 75, 101743. https://doi.org/10.1016/j.lmot.2021.101743

Scoriels, L., Genaro, L. T., Mororó, L. G. C., Keffer, S., Luiza, A., Guimarães, D. V., Ribeiro, P. V. S., Tannos, F. M., Novaes, C., França, A. I., Goldenstein, N., Sahakian, B. J., Cavalcanti, M. T., Fisher, M., Vinogradov, S., & Panizzutti, R. (2020). Auditory versus visual neuroscience-informed cognitive training in schizophrenia: Effects on cognition, symptoms and quality of life. Schizophrenia Research, 222, 319-326. https://doi.org/10.1016/j.schres.2020.05.017

More

Toll, A., Bergé, D., Burling, K., Scoriels, L., Treen, D., Monserrat, C., Marmol, F., Duran, X., Jones, P. B., Pérez-Solà, V., Fernandez-Egea, E., & Mané, A. (2020). Cannabis use influence on peripheral brain-derived neurotrophic factor levels in antipsychotic-naïve first-episode psychosis. European Archives of Psychiatry and Clinical Neuroscience, 270(7), 851–858. https://doi.org/10.1007/s00406-020-01117-y

Scoriels, L., Zimbron, J., Garcia-León, N., Coll-Negre, M., Giro, M., Perez, J., Jones, P. B., & Fernandez-Egea, E. (2019). Cross-sectional study of diet patterns in early and chronic schizophrenia. Schizophrenia Research, 208. https://doi.org/10.1016/j.schres.2019.03.029

Lennox, B. R., Palmer-Cooper, E. C., Pollak, T., Hainsworth, J., Marks, J., Jacobson, L., Lang, B., Fox, H., Ferry, B., Scoriels, L., Crowley, H., Jones, P. B., Harrison, P. J., & Vincent, A. (2017). Prevalence and clinical characteristics of serum neuronal cell surface antibodies in first-episode psychosis: A case-control study. The Lancet Psychiatry, 4(1). https://doi.org/10.1016/S2215-0366(16)30375-3

More

Lennox, B. R., Pollak, T., Palmer-Cooper, E. C., Scoriels, L., Harrison, P. J., Jones, P. B., Lang, B., Crowley, H., Marks, J., & Vincent, A. (2017). Serum neuronal cell-surface antibodies in first-episode psychosis–Authors’ reply. The Lancet Psychiatry, 4(3). https://doi.org/10.1016/S2215-0366(17)30053-6

Calderon, J., Flores, P., Aguirre, J. M., Valdivia, G., Padilla, O., Barra, I., Scoriels, L., Herrera, S., Gonzalez, A., & Massardo, L. (2016). Impact of cognitive impairment, depression, disease activity, and disease damage on quality of life in women with systemic lupus erythematosus. Scandinavian Journal of Rheumatology, 1–8. https://doi.org/10.1080/03009742.2016.1206617

Scoriels, L., Avellar, M., Madeira, C., Vargas-Lopes, C., Marques, P., Dantas, C., Manhães, A. C., Leite, H., & Panizzutti, R. (2016). The effect of D-serine administration on cognition and mood in older adults. Oncotarget, 7(11). https://doi.org/10.18632/oncotarget.7691

More

Xu, M. K., Gaysina, D., Barnett, J. H., Scoriels, L., van de Lagemaat, L. N., Wong, a, Richards, M., Croudace, T. J., & Jones, P. B. (2015). Psychometric precision in phenotype definition is a useful step in molecular genetic investigation of psychiatric disorders. Translational Psychiatry, 5(6), e593–e593. https://doi.org/10.1038/tp.2015.86

More

Scoriels, L., Salek, R. M., Goodby, E., Grainger, D., Dean, a M., West, J. a, Griffin, J. L., Suckling, J., Nathan, P. J., Lennox, B. R., Murray, G. K., Bullmore, E. T., & Jones, P. B. (2015). Behavioural and molecular endophenotypes in psychotic disorders reveal heritable abnormalities in glutamatergic neurotransmission. Translational Psychiatry, 5(January), e540–e540. https://doi.org/10.1038/tp.2015.26

More

Massardo, L., Bravo-Zehnder, M., Calderón, J., Flores, P., Padilla, O., Aguirre, J. M., Scoriels, L., & González, a. (2015). Anti-N-methyl-D-aspartate receptor and anti-ribosomal-P autoantibodies contribute to cognitive dysfunction in systemic lupus erythematosus. Lupus, 24(6), 558–568. https://doi.org/10.1177/0961203314555538

Panizzutti, R., Scoriels, L., & Avellar, M. (2014). The co-agonist Site of NMDA-glutamate receptors: A novel therapeutic target for age-related cognitive decline. Curr Pharm Des, 20(32), 5160–5168.

Zandi, M. S., Deakin, J. B., Morris, K., Buckley, C., Jacobson, L., Scoriels, L., Cox, A. L., Coles, A. J., Jones, P. B., Vincent, A., & Lennox, B. R. (2014). Immunotherapy for patients with acute psychosis and serum N-Methyl d-Aspartate receptor (NMDAR) antibodies: A description of a treated case series. Schizophrenia Research, 160(1–3). https://doi.org/10.1016/j.schres.2014.11.001

Calderón, J., Flores, P., Babul, M., Aguirre, J., Slachevsky, a, Padilla, O., Scoriels, L., Henríquez, C., Cárcamo, C., Bravo-Zehnder, M., González, a, & Massardo, L. (2014). Systemic lupus erythematosus impairs memory cognitive tests not affected by depression. Lupus, 2014, 1042–1053. https://doi.org/10.1177/0961203314536247

Fernandez-Egea, E., Scoriels, L., Theegala, S., Giro, M., Ozanne, S. E., Burling, K., & Jones, P. B. (2013). Cannabis use is associated with increased CCL11 plasma levels in young healthy volunteers. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 46, 25–28. https://doi.org/10.1016/j.pnpbp.2013.06.011

Dean, a M., Goodby, E., Ooi, C., Nathan, P. J., Lennox, B. R., Scoriels, L., Shabbir, S., Suckling, J., Jones, P. B., Bullmore, E. T., & Barnes, A. (2013). Speed of facial affect intensity recognition as an endophenotype of first-episode psychosis and associated limbic-cortical grey matter systems. Psychological Medicine, 43(3), 591–602. https://doi.org/10.1017/S0033291712001341

Scoriels, L., Jones, P. B., & Sahakian, B. J. (2013). Modafinil effects on cognition and emotion in schizophrenia and its neurochemical modulation in the brain. Neuropharmacology, 64, 168–184. https://doi.org/10.1016/j.neuropharm.2012.07.011

Scoriels, L., Barnett, J. H., Soma, P. K., Sahakian, B. J., & Jones, P. B. (2012). Effects of modafinil on cognitive functions in first episode psychosis. Psychopharmacology, 220(2), 249–258. https://doi.org/10.1007/s00213-011-2472-4

Barnett, J. H., Scoriels, L., & Munaf, M. R. (2011). Reply to: With great power comes great responsibility: Meta-analytic proof for a timeless insight. Biological Psychiatry, 69(10). https://doi.org/10.1016/j.biopsych.2010.11.028

Scoriels, L., Barnett, J. H., Murray, G. K., Cherukuru, S., Fielding, M., Cheng, F., Lennox, B. R., Sahakian, B. J., & Jones, P. B. (2011). Effects of modafinil on emotional processing in first episode psychosis. Biological Psychiatry, 69(5), 457–464. https://doi.org/10.1016/j.biopsych.2010.09.043

Scoriels, L., Barnett, J., & Jones Peter, B. (2010). Modafinil for schizophrenia. Cochrane Database of Systematic Reviews, 9. https://doi.org/10.1002/14651858.CD008661

Kirkbride, J. B., & Scoriels, L. (2009). Review of the 6th symposium for the search for the causes of schizophrenia, Sao Paulo, Brazil, 3-6 February 2009. European Archives of Psychiatry and Clinical Neuroscience, 259(8), 505–509. https://doi.org/10.1007/s00406-009-0025-1

Barnett, J. H., Scoriels, L., & Munafò, M. R. (2008). Meta-Analysis of the Cognitive Effects of the Catechol-O-Methyltransferase Gene Val158/108Met Polymorphism. Biological Psychiatry, 64(2), 137–144. https://doi.org/10.1016/j.biopsych.2008.01.005

Mechawar, N., Saghatelyan, A., Grailhe, R., Scoriels, L., Gheusi, G., Gabellec, M.-M., Lledo, P.-M., & Changeux, J.-P. (2004). Nicotinic receptors regulate the survival of newborn neurons in the adult olfactory bulb. Proceedings of the National Academy of Sciences of the United States of America, 101(26), 9822–9826. https://doi.org/10.1073/pnas.0403361101

More
bottom of page